Author Question: The Sweet Factory produces and sells specialty fudge. The selling price per pound is $20, variable ... (Read 113 times)

luvbio

  • Hero Member
  • *****
  • Posts: 623
The Sweet Factory produces and sells specialty fudge.  The selling price per pound is $20, variable costs are $12 per pound, and total fixed costs are $6,000.


How many pounds of fudge must The Sweet Factory sell to break-even?
◦ 300
◦ 750
◦ 15,000
◦ 188



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question

daltonest1984

  • Hero Member
  • *****
  • Posts: 536
The Sweet Factory produces and sells specialty fudge.  The selling price per pound is $20, variable costs are $12 per pound, and total fixed costs are $6,000.


What are break-even sales in dollars at The Sweet Factory?
◦ $9,000
◦ $3,750
◦ $15,000
◦ $750




 

Did you know?

Signs and symptoms of a drug overdose include losing consciousness, fever or sweating, breathing problems, abnormal pulse, and changes in skin color.

Did you know?

The Romans did not use numerals to indicate fractions but instead used words to indicate parts of a whole.

Did you know?

Tobacco depletes the body of vitamins A, C, and E, which can result in any of the following: dry hair, dry skin, dry eyes, poor growth, night blindness, abscesses, insomnia, fatigue, reproductive system problems, sinusitis, pneumonia, frequent respiratory problems, skin disorders, weight loss, rickets, osteomalacia, nervousness, muscle spasms, leg cramps, extremity numbness, bone malformations, decayed teeth, difficulty in walking, irritability, restlessness, profuse sweating, increased uric acid (gout), joint damage, damaged red blood cells, destruction of nerves, infertility, miscarriage, and many types of cancer.

Did you know?

Women are two-thirds more likely than men to develop irritable bowel syndrome. This may be attributable to hormonal changes related to their menstrual cycles.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library